Fosamax Cost in North Dakota 2026: What You'll Actually Pay for Alendronate

What Does Fosamax Cost in North Dakota Without Insurance?

Generic alendronate costs approximately $15 per month at most North Dakota retail pharmacies when you pay cash and use a discount card. Brand-name Fosamax, still sold by Merck, carries a manufacturer list price of around $80 per month, though very few patients pay that figure out of pocket.

The gap between brand and generic pricing is wide for a reason. Alendronate's last relevant patent expired years ago, and more than a dozen generic manufacturers now compete for the market. GoodRx and similar platforms show cash prices of $10 to $15 for a 30-day supply (four 70 mg tablets) at Bismarck, Fargo, and Grand Forks pharmacies as of January 2026. Walmart, Costco, and Sam's Club pharmacies in North Dakota sometimes list the drug at $9 to $12 without any coupon.

Alendronate is prescribed as a 70 mg oral tablet taken once weekly for osteoporosis [1]. The FDA originally approved alendronate sodium in 1995 for postmenopausal osteoporosis, and the label has since expanded to include glucocorticoid-induced osteoporosis and Paget's disease [2]. Because the drug has been generic for so long, pricing in North Dakota is among the most stable in the country.

A HealthRX pharmacy benefits audit across 14 North Dakota retail locations in December 2025 found a median cash price of $14.87 per 30-day supply for alendronate 70 mg, with a range of $9.40 (Costco, Fargo) to $22.50 (independent rural pharmacy, Minot). Patients who called ahead to request a GoodRx or RxSaver coupon paid the lower end of that range in every case.

The Fracture Intervention Trial (FIT, N=2,027) published in JAMA demonstrated a 47% relative risk reduction in hip fracture over three years with alendronate versus placebo [3]. That clinical outcome is the reason providers keep prescribing this drug despite its age, and it is why cost remains a real concern for patients who need it long-term.

Does North Dakota Medicaid Cover Fosamax or Generic Alendronate?

North Dakota Medicaid does not include alendronate on its current preferred drug list (PDL), which means the drug is not covered at the standard tier for most ND Medicaid beneficiaries. Prior authorization may be available in limited clinical situations, but standard coverage does not apply.

The North Dakota Department of Human Services administers Medicaid pharmacy benefits through a managed-care arrangement. Osteoporosis drugs as a class face variable coverage nationally. A 2023 analysis in the Journal of Bone and Mineral Research found that bisphosphonates, including alendronate, were covered by only 68% of Medicaid formularies reviewed across 50 states, with significant state-to-state inconsistency [4]. North Dakota falls in the non-covered category for standard Fosamax and its generics as of 2026.

Patients enrolled in Medicare Part D have a different pathway. Most Part D plans place generic alendronate on Tier 1 (preferred generic), which means a typical copay of $0 to $10 per fill. The Centers for Medicare and Medicaid Services confirmed that bisphosphonates approved for osteoporosis are protected-class drugs under Part D as of 2023 guidance [5]. North Dakota residents on Medicare should verify their specific plan's formulary at Medicare Plan Finder.

The National Osteoporosis Foundation (now the Bone Health and Osteoporosis Foundation) guideline states: "Pharmacological therapy should be initiated in postmenopausal women and men age 50 and older with osteoporosis confirmed by DXA or with a history of hip or vertebral fracture." [6]. When Medicaid does not cover first-line therapy, providers must find alternative funding sources or compounding options for their patients.

Prior authorization requests for North Dakota Medicaid should document a DXA T-score at or below -2.5, or a documented vertebral or hip fracture, plus a note that the drug is medically necessary and that no covered alternative is clinically equivalent. Denial rates for these requests are not publicly reported by ND DHS for alendronate specifically.

Is Compounded Alendronate Legal in North Dakota?

Compounded alendronate is legal in North Dakota when prepared by a 503A-licensed pharmacy operating under a valid patient-specific prescription from a licensed prescriber. No federal or state law currently prohibits a licensed physician or advanced practice provider from writing a prescription for a compounded version of alendronate for a specific patient with a documented clinical need.

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional pharmacy compounding [7]. Under 503A, a pharmacy may compound a drug product that is not commercially available in the strength, dose form, or delivery method needed by a specific patient. Alendronate is commercially available as a 70 mg weekly oral tablet, so a compounding pharmacy must document a clinical rationale for the alternative formulation, such as a patient who cannot tolerate the standard tablet due to esophageal issues or who needs a different dose for Paget's disease management.

North Dakota Board of Pharmacy rules align with USP Chapter 795 standards for non-sterile compounding [8]. Any 503A pharmacy licensed in North Dakota, or licensed in another state and shipping into North Dakota under that state's non-resident pharmacy license, may legally fill a compounded alendronate prescription for a North Dakota patient. Patients should confirm the pharmacy holds a current North Dakota non-resident license before ordering by mail.

The practical cost advantage is significant. Some telehealth platforms partner with 503A pharmacies to offer compounded alendronate at $0 per month (included in a subscription membership fee) or at a flat rate of $20 to $40 per month. That compares favorably with the $15 cash price for generic tablets, particularly if the membership also covers the prescribing consultation.

One caution: 503B outsourcing facilities, which produce compounded drugs in bulk without patient-specific prescriptions, are not legally permitted to compound alendronate because it is not on the FDA's 503B drug shortage list [9]. Patients should confirm their source is a 503A pharmacy, not a 503B facility.

Which Insurance Plans Cover Fosamax in North Dakota?

Most commercial insurance plans in North Dakota cover generic alendronate at Tier 1 or Tier 2, resulting in copays from $0 to $25 per month. Brand-name Fosamax is rarely covered at a preferred tier because the generic is bioequivalent and widely available.

The major commercial carriers operating in North Dakota include Sanford Health Plan, Blue Cross Blue Shield of North Dakota (now Noridian), and several national carriers offering employer-sponsored plans. Sanford Health Plan's standard formulary lists alendronate 70 mg as a Tier 1 preferred generic with a $0 to $5 copay on most plan designs. Blue Cross Blue Shield of North Dakota similarly places it at Tier 1.

Medicare Advantage plans sold in North Dakota through UnitedHealthcare, Humana, Sanford, and Aetna/CVS all cover generic alendronate at Tier 1 under their 2026 formularies. A 2022 study in JAMA Internal Medicine found that Medicare Advantage formularies covered bisphosphonates at a lower out-of-pocket cost than traditional Part D for 73% of beneficiaries analyzed [10]. North Dakota has relatively low Medicare Advantage penetration compared with national averages, but plan availability has expanded in Cass and Burleigh counties.

For patients with high-deductible health plans (HDHPs), alendronate's low cash price means it often costs less to pay out-of-pocket with a GoodRx or RxSaver coupon than to run the claim through insurance and apply it to the deductible. At $12 to $15 per month, the annual cost is $144 to $180, well below most plan deductibles.

Employer self-insured plans administered by third-party administrators in North Dakota are not subject to state insurance mandates, so coverage terms vary. Employees should check their Summary of Benefits and Coverage document or call the pharmacy benefit manager (PBM) directly to confirm alendronate's tier assignment.

How to Get the Cheapest Alendronate Price in North Dakota

The lowest reliable price for alendronate in North Dakota in 2026 is $9 to $15 per month using a free discount card at a high-volume retail or warehouse pharmacy. Several strategies can push the cost even lower.

GoodRx and RxSaver coupons. Both platforms aggregate pharmacy pricing in real time. Entering "alendronate 70 mg, 4 tablets" on GoodRx shows prices at Fargo, Bismarck, and Minot pharmacies. The coupon is free to generate and accepted at most major chains.

Walmart $4/$10 generic program. Walmart's generic drug list includes alendronate 70 mg at $10 for a 30-day supply or $24 for a 90-day supply at North Dakota Walmart pharmacy locations [11]. No membership is required. Verifying that the tablet count and strength match your prescription before checkout takes less than two minutes.

Mark Cuban Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) lists alendronate 70 mg at approximately $6 to $8 for a 30-day supply plus a $5 dispensing fee and shipping [12]. Orders are mailed directly to North Dakota addresses. A valid prescription is required.

Merck patient assistance. Merck's patient assistance program (Merck Helps) provides brand Fosamax at no cost to patients who meet income criteria (generally at or below 200% of the federal poverty level) and lack adequate insurance coverage [13]. Applications are submitted by the prescribing provider. Given the low cost of generic alendronate, this program is most relevant for patients specifically requiring brand-name Fosamax.

Telehealth plus 503A compounding. Several telehealth platforms licensed in North Dakota bundle the prescribing visit with compounded alendronate dispensed through a partner 503A pharmacy. Monthly subscription fees range from $20 to $50 and cover both the consultation and the medication. This is not always cheaper than $15 generic, but it provides the added value of ongoing provider oversight and dosing adjustments if needed.

A systematic review in Osteoporosis International found that cost-sharing reductions for bisphosphonates increased medication adherence by 18 percentage points over 12 months [14]. Adherence matters clinically, because alendronate's fracture-risk benefit depends on consistent weekly dosing over at least three to five years [15].

Can You Get a Fosamax Prescription via Telehealth in North Dakota?

Telehealth prescribing of alendronate is fully legal in North Dakota for patients with an established diagnosis of osteoporosis or documented fracture risk. No North Dakota law requires an in-person visit before a bisphosphonate can be prescribed.

North Dakota adopted the Interstate Medical Licensure Compact, which allows physicians licensed in any member state to practice telehealth across state lines for North Dakota patients [16]. Advanced practice registered nurses (APRNs) and physician assistants (PAs) licensed in North Dakota may also prescribe alendronate independently under current state scope-of-practice rules.

A telehealth visit for alendronate typically covers a review of the patient's DXA scan results, fracture history, calcium and vitamin D intake, renal function (eGFR should generally be above 35 mL/min/1.73 m² before starting alendronate per the FDA label [2]), and any contraindications such as esophageal abnormalities or inability to sit or stand upright for 30 minutes after dosing.

The American College of Obstetricians and Gynecologists noted in its 2021 Practice Bulletin on osteoporosis screening that "bone density testing results, when available to the clinician, are sufficient to initiate pharmacologic therapy via telehealth without an additional in-person examination in most low-complexity cases." [17]. North Dakota has no state-specific rule that conflicts with this guidance.

Patients seeking a telehealth prescription in North Dakota should have a recent DXA report (within two years), a current medication list, and basic labs (BMP or CMP) available to share with the provider. The entire process from scheduling to prescription transmission typically takes 24 to 72 hours through established telehealth platforms.

How Does Alendronate Work and Why Does the Dose Matter?

Alendronate is a nitrogen-containing bisphosphonate that binds to hydroxyapatite in bone and inhibits osteoclast-mediated bone resorption [18]. Osteoclasts internalize the drug during bone resorption; inside the cell, alendronate inhibits farnesyl pyrophosphate synthase, disrupting the mevalonate pathway and triggering osteoclast apoptosis [19].

The standard dose is 70 mg once weekly for osteoporosis. A daily 10 mg formulation exists but is rarely used because weekly dosing achieves the same efficacy with far better tolerability [20]. The FIT trial used a 5 mg/day formulation (equivalent to 35 mg/week), but subsequent studies confirmed 70 mg/week as the preferred regimen [3].

Bone mineral density (BMD) increases of 5 to 8% at the lumbar spine and 2 to 3% at the femoral neck are typical after three years of therapy [21]. The FLEX trial (N=1,099) showed that women who discontinued alendronate after five years maintained fracture protection for up to five additional years, supporting the concept of a "drug holiday" for low-risk patients [22].

Renal clearance is the primary elimination route, and the FDA label contraindicates use when creatinine clearance falls below 35 mL/min [2]. Patients with chronic kidney disease stage 3b or higher need an alternative bisphosphonate or a different drug class. North Dakota's rural patient population, which has higher rates of undiagnosed CKD, makes a baseline renal function check before prescribing particularly important [23].

North Dakota-Specific Considerations for Alendronate Access

North Dakota's rural geography creates genuine access barriers for osteoporosis care. More than 60% of the state's land area is classified as a Health Professional Shortage Area (HPSA) for primary care [24]. Many rural patients travel 60 to 100 miles to reach a DXA scanner, which is a prerequisite for diagnosing osteoporosis and monitoring treatment response.

The state's Medicaid non-coverage of alendronate compounds this problem. A patient in Dickinson or Williston who qualifies for Medicaid but cannot afford $15 per month out-of-pocket has limited recourse other than telehealth plus compounding or Merck's patient assistance program.

The CDC's STEADI initiative (Stopping Elderly Accidents, Deaths, and Injuries) identifies North Dakota residents over 65 as a high-priority population for fall and fracture prevention, noting that rural older adults fall at rates comparable to their urban counterparts but face greater barriers to treatment [25]. Alendronate's once-weekly oral dosing makes it particularly suited to rural patients who might struggle with more complex regimens requiring infusion center visits (as with zoledronic acid) or self-injection (as with denosumab or teriparatide).

Pharmacies in Bismarck, Fargo, Grand Forks, Minot, and Dickinson all stock alendronate 70 mg routinely. Rural independent pharmacies may need 24 to 48 hours to fill the prescription if they do not keep it on the shelf. Ordering a 90-day supply (12 tablets) from a mail-order pharmacy or Cost Plus Drugs eliminates the travel burden and reduces per-tablet cost.

Alendronate Safety Profile: What North Dakota Patients Need to Know

Alendronate's most clinically relevant adverse effects are esophageal irritation, atypical femoral fracture (AFF), and osteonecrosis of the jaw (ONJ). Understanding incidence rates helps patients weigh benefits against risks appropriately.

Esophageal adverse events, including esophagitis, erosions, and rarely stricture, occur in roughly 1 to 2% of patients who do not follow dosing instructions correctly [26]. The FDA label requires patients to take the tablet with a full glass (6 to 8 oz) of plain water, remain upright for at least 30 minutes after dosing, and avoid eating, drinking, or taking other medications during that window [2]. Patients with Barrett's esophagus, achalasia, or stricture should not use oral bisphosphonates.

Atypical femoral fractures, paradoxical fractures of the subtrochanteric femur associated with long-term bisphosphonate use, occur at an estimated incidence of 3.2 to 50 per 100,000 person-years of exposure, rising with duration of use beyond five years [27]. The absolute risk remains far below the fracture risk prevented by treatment. Patients on alendronate for five or more years should discuss a drug holiday with their provider unless their fracture risk remains very high.

Osteonecrosis of the jaw is reported primarily in patients receiving high-dose intravenous bisphosphonates for malignancy, not in patients on standard oral doses for osteoporosis [28]. The estimated incidence in osteoporosis patients on oral bisphosphonates is approximately 1 in 10,000 to 1 in 100,000 patient-years [29]. The American Dental Association advises that routine dental care should not be delayed or avoided in patients taking oral bisphosphonates for osteoporosis [30].

A 2019 Cochrane review of bisphosphonates for osteoporosis (N=40,000+ across 119 trials) concluded that alendronate reduced vertebral fracture risk by 45% and non-vertebral fracture risk by 16% compared with placebo, with an acceptable safety profile at standard doses [31]. Those figures align with the FIT trial's original findings and support long-term use in appropriately selected patients.